Evoxac
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Cevimeline (Evoxac ®) is an oral muscarinic agent that has been recently approved for the treatment of xerostomia in the setting…
OBJECTIVE
The aim of the present study was to compare the effect of low-dose pilocarpine and cevimeline as stimulants for…
M1 muscarinic receptors (M1 mAChRs) play a role in an apparent linkage of three major hallmarks of Alzheimer’s disease (AD…
Muscarinic M3 receptors exist in the gastrointestinal wall in humans and the muscarinic M3 agonist cevimeline hydrochloride…
Irrigation of the salivary gland using a corticosteroid is one of the most successful approaches to improving xerostomia in…
The M1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren’s Syndrome), AF150(S) and AF267B…